Приказ основних података о документу
Association between unfavorable lipid profile and glycemic control in patients with type 2 diabetes mellitus
dc.creator | Klisić, Aleksandra | |
dc.creator | Kavarić, Nebojša | |
dc.creator | Jovanović, Milovan | |
dc.creator | Zvrko, Elvir | |
dc.creator | Skerović, Verica | |
dc.creator | Šćepanović, Anđelka | |
dc.creator | Medin, Darko | |
dc.creator | Ninić, Ana | |
dc.date.accessioned | 2019-09-02T11:58:19Z | |
dc.date.available | 2019-09-02T11:58:19Z | |
dc.date.issued | 2017 | |
dc.identifier.issn | 1735-1995 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/2835 | |
dc.description.abstract | Background: Recent studies hypothesize that dyslipidemia can predict glycated hemoglobin (HbA1c) and could be important contributing factor to the pathogenesis of type 2 diabetes mellitus (DM2). Therefore, we aimed to evaluate the influence of lipid parameters on long-term glycemic control in DM2. Materials and Methods: A total of 275 sedentary DM2 (mean [+/- standard deviation] age 60.6 [+/- 10.0] years) who volunteered to participate in this cross-sectional study were enrolled. Anthropometric (body weight, body hight, and waist circumference), biochemical parameters (fasting glucose, HbA1c, lipid parameters, creatinine), as well as blood pressure were obtained. Results: Total cholesterol (odds ratio [OR] = 1.30, 95% confidence interval [CI] [1.02-1.66], P = 0.032), triglycerides (OR = 1.34, 95% CI (1.07-1.67), P = 0.010), and low density lipoprotein cholesterol (OR = 1.42, 95% CI [1.10-1.83], P = 0.006) were the independent predictors of higher HBA1c, and as they increased by 1 mmol/L each, probabilities of higher HBA1c increased by 30%, 34%, and 42%, respectively. Low level of high-density lipoprotein cholesterol (HDL-c) was found to be the independent predictor of higher HBA1c (OR = 0.44, 95% CI [0.20-0.67], P = 0.039), and increase in HDL-c by 1 mmol/L, reduced the probability of higher HBA1c by 56%. Conclusion: Unfavorable lipid profile can predict HbA1c level in DM2 patients. Early diagnosis of dyslipidemia, as well as its monitoring and maintaining good lipids control can be used as a preventive measure for optimal long-term glycemic control. | en |
dc.publisher | Wolters Kluwer Medknow Publications, Mumbai | |
dc.relation | info:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/175035/RS// | |
dc.rights | openAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | |
dc.source | Journal of Research in Medical Sciences | |
dc.subject | Diabetes mellitus | en |
dc.subject | dyslipidemia | en |
dc.subject | glycated hemoglobin | en |
dc.subject | glycemic control | en |
dc.title | Association between unfavorable lipid profile and glycemic control in patients with type 2 diabetes mellitus | en |
dc.type | article | |
dc.rights.license | BY-NC-SA | |
dcterms.abstract | Шћепановић, Aнђелка; Зврко, Елвир; Клисић, Aлександра; Каварић, Небојша; Јовановић, Милован; Медин, Дарко; Нинић, Aна; Скеровић, Верица; | |
dc.citation.volume | 22 | |
dc.citation.other | 22: - | |
dc.citation.rank | M22 | |
dc.identifier.wos | 000423018600003 | |
dc.identifier.doi | 10.4103/jrms.JRMS_284_17 | |
dc.identifier.pmid | 29259633 | |
dc.identifier.scopus | 2-s2.0-85040723782 | |
dc.identifier.fulltext | https://farfar.pharmacy.bg.ac.rs//bitstream/id/1467/2833.pdf | |
dc.type.version | publishedVersion |